Articles

Collaborative oncology care, which involves incorporating an advanced practitioner (AP) into an oncology practice, will help meet the growing burden of complex care and improve patient satisfaction. Read More ›

Advances in technology and decreased testing costs have led to a rise in the number of genes associated with inherited cancer risk for which testing is clinically available. Read More ›

The prevalence of malnutrition in patients with lung cancer is particularly high, but early and intensive individualized dietary counseling can improve quality of life for these patients and decrease their chances of experiencing significant weight loss. Read More ›

Sexual dysfunction is a common problem for cancer survivors, and nurses can be a part of the solution by addressing this issue, educating themselves, and joining with other health professionals who care about patients’ sexual health. Read More ›

Oncology nurses may believe that personal exposure to hazardous drugs is a thing of the past, but they would be wrong. Read More ›

Hypofractionated radiotherapy achieves comparable quality of life compared with conventional radiotherapy, and has the advantages of shorter treatment time, greater convenience to the patient, and less cost to the healthcare system compared with conventional radiotherapy. Read More ›

It is well-recognized that radiation-induced symptoms can be extremely severe for patients with head and neck cancer. Although “magic mouthwash” (ie, diphenhydramine plus lidocaine plus antacid [DLA]) is frequently used for the treatment of oral mucositis associated with radiotherapy to the head and neck, until now there has been no solid evidence for this approach. Read More ›

In the United States, the 3.1 million registered nurses (RNs) account for the largest health profession, and this is projected to grow by 33% by 2025 (from 2012). Read More ›

Women with clinicopathologic high-risk breast cancer had nearly a 50% reduction in prescription chemotherapy, with no increased risk for metastatic recurrence when a cancer gene–based assay was used to guide treatment decision­-making, according to new data presented at the 2016 American Association for Cancer Research meeting.

Read More ›

SGX942, a novel agent that is first in its class, decreased the incidence of severe oral mucositis in patients with head and neck cancer undergoing chemoradiation, according to new research. Read More ›